prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - površinski antigeni virusa influence (hemaglutinin in nevraminidaza) seva a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - cepiva - aktivna imunizacija proti podtipu h5n1 virusa influenca a. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
tegretol 200 mg tablete
novartis pharma gmbh - karbamazepin - tableta - karbamazepin 200 mg / 1 tableta - karbamazepin
tegretol cr 400 mg tablete s podaljšanim sproščanjem
novartis pharma gmbh - karbamazepin - tableta s podaljšanim sproščanjem - karbamazepin 400 mg / 1 tableta - karbamazepin
sandostatin 0,05 mg/ml raztopina za injiciranje/infundiranje
novartis pharma gmbh - oktreotid - raztopina za injiciranje/infundiranje - oktreotid 0,05 mg / 1 ml - oktreotid
sandostatin 0,1 mg/ml raztopina za injiciranje/infundiranje
novartis pharma gmbh - oktreotid - raztopina za injiciranje/infundiranje - oktreotid 0,1 mg / 1 ml - oktreotid
sandostatin lar 10 mg prašek in vehikel za suspenzijo za injiciranje
novartis pharma gmbh - oktreotid - prašek in vehikel za suspenzijo za injiciranje - oktreotid 10 mg / 1 viala - oktreotid
sandostatin lar 20 mg prašek in vehikel za suspenzijo za injiciranje
novartis pharma gmbh - oktreotid - prašek in vehikel za suspenzijo za injiciranje - oktreotid 20 mg / 1 viala - oktreotid
sandostatin lar 30 mg prašek in vehikel za suspenzijo za injiciranje
novartis pharma gmbh - oktreotid - prašek in vehikel za suspenzijo za injiciranje - oktreotid 30 mg / 1 viala - oktreotid
sandostatin 0,5 mg/ml raztopina za injiciranje/infundiranje
novartis pharma gmbh - oktreotid - raztopina za injiciranje/infundiranje - oktreotid 0,5 mg / 1 ml - oktreotid
icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - vildagliptin, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).